Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure - Trial NCT06418932
Access comprehensive clinical trial information for NCT06418932 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación para la Investigación del Hospital Clínico de Valencia and is currently Recruiting. The study focuses on Heart Failure. Target enrollment is 106 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fundación para la Investigación del Hospital Clínico de Valencia
Timeline & Enrollment
N/A
May 07, 2024
Jul 01, 2026
Primary Outcome
Natriuresis,Weight
Summary
Randomized 1:1 multicenter double-blind clinical investigation evaluating the efficacy and
 safety of compression therapy of the lower limbs plus parenteral administration of diuretics
 vs. administration of parenteral diuretics alone (standard treatment) in patients with
 decompensated HF and predominantly systemic tissue congestion and absence of intravascular
 systemic congestion.
 
 Patients will be assigned to standard treatment (parenteral administration of furosemide)
 versus parenteral administration of furosemide plus lower limb compression therapy for up to
 72 hours. The dose of furosemide in all participants will be based on the clinical judgment
 of the responsible healthcare professional.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06418932
Device Trial